scispace - formally typeset
M

Marion H. Brown

Researcher at University of Oxford

Publications -  70
Citations -  7213

Marion H. Brown is an academic researcher from University of Oxford. The author has contributed to research in topics: Receptor & Ligand (biochemistry). The author has an hindex of 37, co-authored 70 publications receiving 6760 citations. Previous affiliations of Marion H. Brown include London Research Institute.

Papers
More filters
Journal ArticleDOI

Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)

TL;DR: In diverse tissues OX2 delivers an inhibitory signal for the macrophage lineage, and outside the brain, disruption of CD200-CD200 receptor interaction precipitated susceptibility to collagen-induced arthritis in mice normally resistant to this disease.
Journal ArticleDOI

CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.

TL;DR: It is concluded that CD147 facilitates proper expression of MCT1 and MCT4 at the cell surface, where they remain tightly bound to each other, and may also be important in determining their activity and location.
Journal ArticleDOI

Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

TL;DR: The first characterization of human CD200R (hCD200R) is reported and its binding characteristics to hCD200 are defined, and two mCD200 receptor-like family members were shown to pair with the activatory adaptor protein, DAP12, suggesting that these receptors would transmit strong activating signals in contrast to the apparent inhibitory signal delivered by triggering the CD 200R.
Journal ArticleDOI

CD200 and membrane protein interactions in the control of myeloid cells

TL;DR: The unusual tissue distribution of CD200 indicates where myeloid cells can be restrictively controlled through cell-cell contact.
Journal ArticleDOI

2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48

TL;DR: The finding of an additional ligand for CD48 provides an explanation for distinct functional effects observed on perturbing CD2 and CD48 with mAbs or by genetic manipulation.